TNFRSF14 aberrations in follicular lymphoma increase clinically significant allogeneic T-cell responses.

Abstract

Donor T-cell immune responses can eradicate lymphomas after allogeneic hematopoietic stem cell transplantation (AHSCT), but can also damage healthy tissues resulting in harmful graft-versus-host disease (GVHD). Next-generation sequencing has recently identified many new genetic lesions in follicular lymphoma (FL). One such gene, tumor necrosis factor… (More)
DOI: 10.1182/blood-2015-10-679191

Topics

7 Figures and Tables